Macrophage activation is central to PNI pathogenesis, transitioning from a proinflammatory (M1) to an anti-inflammatory (M2) phenotype with distinct functions in inflammation and repair
Backed by more than 80 years of science and medical data, these products have been selected for superior bioavailability and can help ensure a complete and personalized approach to meet your health goals.
Focus on Ulcerative Colitis: Stable Gastric Pentadecapeptide BPC 157
Neurostimulation for drug-resistant epilepsy: a systematic review of clinical evidence for efficacy, safety, contraindications and predictors for response
BPC-157 - Body Protection Compound 157 BPC-157 Body Protection Compound 157 BPC-157 is a gastric protein-derived peptide fragment commonly studied in models examining cellular signaling, vascular-related communication, and tissue-level coordination
It reflects, in part, the absence of the clinical trial, safety monitoring, and post-market surveillance costs embedded in the price of FDA-approved products